Yubo International Biotech Ltd (YBGJ) › Operating Cash FlowYubo International Biotech Ltd (YBGJ) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$49.0K2012: -$43.0K2013: -$38.0K2014: -$46.0K2015: -$63.0K2016: -$56.0K2017: -$55.0K2018: -$55.0K2019: -$32.0K2020: $101.1K2021: -$1.02M2022: -$601.0K2023: -$739.0K2024: -$1.34M2025: -$842.8K-$842.8K2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$842.8K+37.0%2024-$1.34M-81.0%2023-$739.0K-23.0%2022-$601.0K+41.1%2021-$1.02M-1109.7%2020$101.1K+416.0%2019-$32.0K+41.8%2018-$55.0K+0.0%2017-$55.0K+1.8%2016-$56.0K+11.1%2015-$63.0K-37.0%2014-$46.0K-21.1%2013-$38.0K+11.6%2012-$43.0K+12.2%2011-$49.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share